| 1 |
Gragnani L, Visentini M, Lorini S, Santini SA, Lauletta G, Mazzaro C, Urraro T, Quartuccio L, Cacciapaglia F, Ruscitti P, Tavoni A, Marri S, Cusano G, Petraccia L, Naclerio C, Treppo E, Del Frate G, Di Cola I, Raimondo V, Scorpiniti D, Monti M, Puccetti L, Elia G, Fallahi P, Basili S, Scarpato S, Iannone F, Casato M, Antonelli A, Zignego AL, Ferri C. COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity. J Clin Immunol 2023;:1-12. [PMID: 36795264 DOI: 10.1007/s10875-023-01444-4] [Reference Citation Analysis]
|
| 2 |
Cazzato G, Ambrogio F, Pisani MC, Colagrande A, Arezzo F, Cascardi E, Dellino M, Macorano E, Trilli I, Parente P, Lettini T, Romita P, Marzullo A, Ingravallo G, Foti C. Histopathological Patterns of Cutaneous Adverse Reaction to Anti-SARS-CoV-2 Vaccines: The Integrative Role of Skin Biopsy. Vaccines (Basel) 2023;11. [PMID: 36851273 DOI: 10.3390/vaccines11020397] [Reference Citation Analysis]
|
| 3 |
Salehi S, Sadeghi S, Kalantari Y, Goodarzi A. A Systematic Review of Histopathologic Surveys on Mucocutaneous Biopsies in Patients Developed COVID-19 Vaccine-Related Dermatologic Manifestations. Am J Dermatopathol 2023;45:1-27. [PMID: 36484603 DOI: 10.1097/DAD.0000000000002320] [Reference Citation Analysis]
|
| 4 |
Dehoratius DM. Cutaneous small vessel vasculitis. Postgraduate Medicine 2022. [DOI: 10.1080/00325481.2022.2159207] [Reference Citation Analysis]
|
| 5 |
Corrà A, Verdelli A, Mariotti EB, Ruffo di Calabria V, Quintarelli L, Aimo C, Sunderkötter CH, Caproni M. Cutaneous vasculitis: Lessons from COVID-19 and COVID-19 vaccination. Front Med (Lausanne) 2022;9:1013846. [PMID: 36569148 DOI: 10.3389/fmed.2022.1013846] [Reference Citation Analysis]
|
| 6 |
Chomičienė A, Černiauskas K, Linauskienė K, Meškauskas R, Malinauskienė L. Two case reports of skin vasculitis following the COVID-19 immunization. Open Med (Wars) 2022;17:1944-8. [PMID: 36561846 DOI: 10.1515/med-2022-0608] [Reference Citation Analysis]
|
| 7 |
Rahmanian E, Alikhani M, Loghman M, Beikmohamadi Hezaveh S, Zangeneh S, Shahriarirad R, Faezi ST, Nejadhosseinian M. COVID ‐19 vaccine‐induced vasculitis in a patient with sarcoidosis: A case report. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.6501] [Reference Citation Analysis]
|
| 8 |
Fiorillo G, Bressan A, Cortese A, Toso F, Manara S, Costanzo A. New-onset erythema elevatum diutinum following COVID-19 vaccination. Ital J Dermatol Venerol 2022;157:527-8. [PMID: 36651208 DOI: 10.23736/S2784-8671.22.07351-0] [Reference Citation Analysis]
|
| 9 |
Martora F, Battista T, Marasca C, Genco L, Fabbrocini G, Potestio L. Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature. CCID 2022;Volume 15:2369-2382. [DOI: 10.2147/ccid.s388245] [Reference Citation Analysis]
|
| 10 |
Himed S, Gray A, Awethe Z, Libson K, Kaffenberger BH, Korman AM, Trinidad JCL. SARS-CoV-2 Infection and Vaccination Cutaneous Manifestations for the Inpatient Dermatologist. Curr Derm Rep. [DOI: 10.1007/s13671-022-00374-5] [Reference Citation Analysis]
|
| 11 |
Singh R, Freeman EE. Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin. Curr Derm Rep. [DOI: 10.1007/s13671-022-00370-9] [Reference Citation Analysis]
|
| 12 |
Carubbi F, Alunno A, Santilli J, Natali L, Mancini B, Di Gregorio N, Del Pinto R, Viscido A, Grassi D, Ferri C. Immune-mediated inflammatory diseases after anti-SARS-CoV-2 vaccines: new diagnoses and disease flares. RMD Open 2022;8:e002460. [DOI: 10.1136/rmdopen-2022-002460] [Reference Citation Analysis]
|
| 13 |
Al-allaf A, Neethu M, Al-allaf Y. A Case Series and Literature Review of the Association of COVID-19 Vaccination With Autoimmune Diseases: Causality or Chance? Cureus 2022. [DOI: 10.7759/cureus.28677] [Reference Citation Analysis]
|
| 14 |
Rodríguez Y, Rojas M, Beltrán S, Polo F, Camacho-Domínguez L, Morales SD, Gershwin ME, Anaya JM. Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review. J Autoimmun 2022;132:102898. [PMID: 36041291 DOI: 10.1016/j.jaut.2022.102898] [Reference Citation Analysis]
|
| 15 |
Maronese CA, Zelin E, Avallone G, Moltrasio C, Romagnuolo M, Ribero S, Quaglino P, Marzano AV. Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic. Front Med 2022;9. [DOI: 10.3389/fmed.2022.996288] [Reference Citation Analysis]
|
| 16 |
Esmaeilzadeh A, Maleki AJ, Moradi A, Siahmansouri A, Yavari MJ, Karami P, Elahi R. Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks. Expert Review of Vaccines. [DOI: 10.1080/14760584.2022.2116008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Ryoo Y, Kim Y, Yun J, Kim S. A Case of Leukocytoclastic Vasculitis Following COVID-19 Vaccination. Keimyung Med J 2022;41:46-49. [DOI: 10.46308/kmj.2022.00010] [Reference Citation Analysis]
|
| 18 |
Li Z, Hu F, Li Q, Wang S, Chen C, Zhang Y, Mao Y, Shi X, Zhou H, Cao X, Peng X. Ocular Adverse Events after Inactivated COVID-19 Vaccination. Vaccines (Basel) 2022;10. [PMID: 35746527 DOI: 10.3390/vaccines10060918] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 19 |
. AZD-1222. Reactions Weekly 2022;1899:77-77. [DOI: 10.1007/s40278-022-12051-2] [Reference Citation Analysis]
|
| 20 |
Theofilis P, Vordoni A, Koukoulaki M, Vlachopanos G, Kalaitzidis RG. Overview of infections as an etiologic factor and complication in patients with vasculitides. Rheumatol Int. [DOI: 10.1007/s00296-022-05100-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
